# A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

> clinical trial · VERIFIED · 2026-08-14

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Carcinoma, Neuroendocrine

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06406465

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.